Feb
13
I’ve been watching this stock in the past 2 months and I have to tell you, I made right decision to add this one to my “stock-watch” list..
Cambridge Heart Inc. (Symbol: CAMH) is a healthcare company, engaged in the research, development, and commercialization of products for the non-invasive diagnosis of cardiac disease. According to the information on their website, Cambridge Heart’s products incorporate its proprietary technology, Microvolt T-Wave Alternans, and are the first diagnostic tools cleared by the U.S. Food and Drug Administration to non-invasively measure microvolt levels of T-wave alternans.

Above is the graph of their stock perfomance in the past 3 months. When I started watching them (which was early in January), the stock was traded at $0.72/share. And now? It’s $1.45/share.
Even though their revenue has declined by 21.9% since last year ($1,089,200 in Q4 2005 vs. $1,394,800 in Q4 2004), but I firmly believe this company is going to be doing well this year since they’ve got good products to sell.
It is not easy to find a company who develop and sell good products, and whose stock is traded less than $5/share. I was pretty luck to come accross this one when I was doing my weekly stock research.
Quote of the Day:
It’s important to be able to make decisions without complete or perfect information. Things are almost never clear on Wall Street, or when they are, then it’s too late to profit from them. – Peter Lynch
Comments
One Response to “A Good Investment Potential in Healthcare Industry”
Leave a Reply
Thanks for the tip on CAMH! Interested in any other good tips.